December 13, 2022
Video
Amit Singal, MD, discusses the FDA approval of durvalumab with tremelimumab (Imjudo) in unresectable hepatocellular carcinoma.
November 11, 2022
Video
Richard Kim, MD, discusses the evaluation of TKI and immunotherapy combination regimens in hepatocellular carcinoma.
November 07, 2022
Video
Rachna T. Shroff, MD, MS, discusses the utility of combining anti–CTLA-4 and anti–PD-1 therapies in hepatocellular carcinoma.
November 03, 2022
Video
Ghassan K. Abou-Alfa, MD, discusses areas ripe for further exploration in hepatocellular carcinoma.
October 18, 2022
Video
Ghassan K. Abou-Alfa, MD, discusses the analysis of disease and patient factors to inform clinical decisions in hepatocellular carcinoma.
October 18, 2022
Video
Laura Goff, MD, discusses how to consider clinical trial information to inform treatment decisions in patients with hepatocellular carcinoma.
October 11, 2022
Video
Rachna T. Shroff, MD, MS, discusses remaining unmet needs for patients with hepatocellular carcinoma.
October 11, 2022
Video
Richard Kim, MD, discusses the evolution of frontline treatment in hepatocellular carcinoma.